Fellowship · New Haven, CT
Sponsored by Yale-New Haven Hospital
Baveno VII - Renewing consensus in portal hypertension.
Journal of hepatology · 2022 · 2,380 citations · Guadalupe Garcia-Tsao
Post-acute COVID-19 syndrome.
Nature medicine · 2021 · 3,389 citations · Tejasav Sehrawat
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Hepatology (Baltimore, Md.) · 2023 · 1,671 citations · Tamar Taddei
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays.
Cell · 2022 · 1,336 citations · Xi Dai
Connecting copper and cancer: from transition metal signalling to metalloplasia.
Nature reviews. Cancer · 2022 · 1,024 citations · Michael Schilsky
Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Lancet (London, England) · 2025 · 275 citations · David Madoff
AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis.
Hepatology (Baltimore, Md.) · 2024 · 370 citations · Guadalupe Garcia-Tsao
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study.
Lancet (London, England) · 2024 · 321 citations · Pamela Kunz